In order to better verify the ability of mG2-scFv to bind to endogenous ICAM1 proteins in different breast cancer cell lines, target cells were examined by IF using mG2-scFv-Fc as the primary antibody (Figure 3C). This evidence concerns the gene ICAM1 and breast cancer.